HIV+ APOE4 carriers are at risk for neurocognitive impairment due to greater disease severity and CSF inflammation.
Submitted by dcc on Thu, 04/28/2016 - 2:43pm
Title | HIV+ APOE4 carriers are at risk for neurocognitive impairment due to greater disease severity and CSF inflammation. |
Publication Type | Presentation |
Year of Publication | 2015 |
Authors | Thames, AD, Briones, MS, Magpantay, LI, Singer, EJ, MartÃnez-Maza, O, Panos, SE, Hinkin, CH, Levine, AJ |
Other Numbers | Presented at the 21st meeting for the Society for Neuroimmune Pharmacology, Miama, FL, April 22-25, 2015 |